Shaik O Rahaman1, Wei Li, Roy L Silverstein. 1. Department of Cell Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA. rahamao@ccf.org
Abstract
OBJECTIVE: Atherosclerosis requires migration of monocytes to the arterial intima, with subsequent differentiation into foam cells. We showed previously that the scavenger receptor CD36 contributes to the activation of Vav family guanine nucleotide exchange factors (Vavs) in aortae from hyperlipidemic apoE-null mice and that oxidatively modified low-density lipoprotein induced CD36-dependent activation of macrophage Vavs in vitro. We also discovered that CD36-dependent uptake of oxidized low-density lipoprotein and foam cell formation were reduced in Vav-deficient macrophages. We now tested the hypothesis that Vavs play a role in atherosclerotic lesion development. APPROACH AND RESULTS: We showed that apoE/vav1 double-null mice fed a Western diet had significant reduction in total aortic lesion area (by en face analysis) compared with apoE-null mice, with no significant differences in body weight or plasma lipid profiles. Histological analysis of aortic sinus lesions showed fewer macrophages and foam cells in double-null mice compared with apoE-null mice, indicating impaired foam cell generation and homing of macrophages to atherosclerotic lesions. An intravital video microscopy-based adhesion assay with fluorescent (Qtracker655)-labeled monocytes showed reduced adhesion of vav1-null monocytes to hyperlipidemic carotid arteries compared with wild-type monocytes. Furthermore, fewer fluorescently labeled vav1-null monocytes accumulated in aortic sinus lesions in hyperlipidemic apoE-null mice. We also found that activation of RhoGTPase Rac and mitogen-activated protein kinase c-Jun N-terminal kinase-2 by CD36-specific oxidized phospholipids was dependent on Vavs. CONCLUSIONS: These results for the first time link Vavs to atherosclerotic lesion development and suggest that Vavs act as critical molecular links coupling hyperlipidemia with proatherogenic monocyte/macrophage responses.
OBJECTIVE:Atherosclerosis requires migration of monocytes to the arterial intima, with subsequent differentiation into foam cells. We showed previously that the scavenger receptor CD36 contributes to the activation of Vav family guanine nucleotide exchange factors (Vavs) in aortae from hyperlipidemic apoE-null mice and that oxidatively modified low-density lipoprotein induced CD36-dependent activation of macrophage Vavs in vitro. We also discovered that CD36-dependent uptake of oxidized low-density lipoprotein and foam cell formation were reduced in Vav-deficient macrophages. We now tested the hypothesis that Vavs play a role in atherosclerotic lesion development. APPROACH AND RESULTS: We showed that apoE/vav1 double-null mice fed a Western diet had significant reduction in total aortic lesion area (by en face analysis) compared with apoE-null mice, with no significant differences in body weight or plasma lipid profiles. Histological analysis of aortic sinus lesions showed fewer macrophages and foam cells in double-null mice compared with apoE-null mice, indicating impaired foam cell generation and homing of macrophages to atherosclerotic lesions. An intravital video microscopy-based adhesion assay with fluorescent (Qtracker655)-labeled monocytes showed reduced adhesion of vav1-null monocytes to hyperlipidemic carotid arteries compared with wild-type monocytes. Furthermore, fewer fluorescently labeled vav1-null monocytes accumulated in aortic sinus lesions in hyperlipidemic apoE-null mice. We also found that activation of RhoGTPase Rac and mitogen-activated protein kinase c-Jun N-terminal kinase-2 by CD36-specific oxidized phospholipids was dependent on Vavs. CONCLUSIONS: These results for the first time link Vavs to atherosclerotic lesion development and suggest that Vavs act as critical molecular links coupling hyperlipidemia with proatherogenic monocyte/macrophage responses.
Authors: Miguel Vicente-Manzanares; Aranzazu Cruz-Adalia; Noa B Martín-Cófreces; José R Cabrero; Mercedes Dosil; Brenda Alvarado-Sánchez; Xosé R Bustelo; Francisco Sánchez-Madrid Journal: Blood Date: 2004-12-23 Impact factor: 22.113
Authors: M Febbraio; E A Podrez; J D Smith; D P Hajjar; S L Hazen; H F Hoff; K Sharma; R L Silverstein Journal: J Clin Invest Date: 2000-04 Impact factor: 14.808
Authors: P Crespo; X R Bustelo; D S Aaronson; O A Coso; M Lopez-Barahona; M Barbacid; J S Gutkind Journal: Oncogene Date: 1996-08-01 Impact factor: 9.867
Authors: Romeo Ricci; Grzegorz Sumara; Izabela Sumara; Izabela Rozenberg; Michael Kurrer; Alexander Akhmedov; Martin Hersberger; Urs Eriksson; Franz R Eberli; Burkhard Becher; Jan Borén; Mian Chen; Myron I Cybulsky; Kathryn J Moore; Mason W Freeman; Erwin F Wagner; Christian M Matter; Thomas F Lüscher Journal: Science Date: 2004-11-26 Impact factor: 47.728
Authors: Zhenze Zhao; Maria C de Beer; Lei Cai; Reto Asmis; Frederick C de Beer; Willem J S de Villiers; Deneys R van der Westhuyzen Journal: Arterioscler Thromb Vasc Biol Date: 2004-10-28 Impact factor: 8.311
Authors: Eugene A Podrez; Eugenia Poliakov; Zhongzhou Shen; Renliang Zhang; Yijun Deng; Mingjiang Sun; Paula J Finton; Lian Shan; Maria Febbraio; David P Hajjar; Roy L Silverstein; Henry F Hoff; Robert G Salomon; Stanley L Hazen Journal: J Biol Chem Date: 2002-07-26 Impact factor: 5.157
Authors: M Angelica Martinez Gakidis; Xavier Cullere; Timothy Olson; Julie L Wilsbacher; Bin Zhang; Sheri L Moores; Klaus Ley; Wojciech Swat; Tanya Mayadas; Joan S Brugge Journal: J Cell Biol Date: 2004-07-12 Impact factor: 10.539